Loading company…
Riskpilot
← Back to search
Sign in
Get full access
MediPlexus Oy
OY
Active
Y-tunnus 3213205-9
Tattariharjuntie 16-B
Medical specialists activities · NACE 8622
Est. 2021
2 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
EUR 483K
+40% vs 2023
EBITDA margin
45.6%
+44% vs 2023
Equity ratio
95.4%
Financial strength
Net profit 2024
EUR 183K
+51% vs 2023
EBITDA — year on year
EUR millions
0M
0M
1M
1M
1M
0M
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
EUR 483K
+40%
EBITDA
EUR 220K
+44%
Net profit
EUR 183K
+51%
Total assets
EUR 498K
+51%
Equity
EUR 475K
+50%
Employees
2
—
Company information
Legal name
MediPlexus Oy
Y-tunnus number
3213205-9
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
24. toukokuuta 2021
Share capital
EUR 0
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsenet ja toimitusjohtaja kukin yksin
Company purpose
Lääkäritoiminta ja hammaslääkäritoiminta.
Contact
Address
Tattariharjuntie 16-B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Helsinki
All Finland companies
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
Income statement
EUR thousands
Item
2022
2023
2024
Revenue
402
344
483
Staff expenses
−142
−119
−88
EBITDA
209
153
220
Depreciation & amort.
−1
−1
−0
EBIT
208
152
220
Net financials
−0
−0
9
Profit before tax
208
152
229
Tax
42
31
46
Net profit
167
122
183
Balance sheet
EUR thousands
Item
2022
2023
2024
Total assets
285
329
498
Equity
213
317
475
Long-term debt
—
0
0
Short-term debt
72
12
23
Total debt
72
12
23
Financial ratios
5-year trend
EBITDA margin
45.6%
This company
15.8%
Market median
+189% vs market
2022
2024
Equity ratio
95.4%
This company
38.2%
Market median
+150% vs market
2022
2024
Return on equity
38.6%
This company
18.4%
Market median
+110% vs market
2022
2024
Net profit margin
38.0%
This company
8.1%
Market median
+369% vs market
2022
2024
Asset turnover
0.97×
This company
1.12×
Market median
+13% vs market
2022
2024
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
SS
Simranjit Singh
Chief Executive Officer
Chief Executive Officer
2021
—
—
MH
Mirja Helena Sinisalo
Deputy auditor
Deputy auditor
2021
—
—
PM
Pirjo Marjatta Saarelainen
Audit
Audit
2021
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
LK
Lakhveer Kaur
Board of Directors
2021
—
—
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of MediPlexus Oy also hold positions in
0
other companies.
Person
Role here
Other companies
Simranjit Singh
Chief Executive Officer
0 companies
Mirja Helena Sinisalo
Deputy auditor
0 companies
Pirjo Marjatta Saarelainen
Audit
0 companies
Lakhveer Kaur
Board of Directors
0 companies